167 related articles for article (PubMed ID: 32692787)
1. Leukotriene receptor antagonist addition to intranasal steroid: systematic review and meta-analysis.
Seresirikachorn K; Mullol J; Limitlaohaphan K; Asvapoositkul V; Snidvongs K
Rhinology; 2021 Feb; 59(1):2-9. PubMed ID: 32692787
[TBL] [Abstract][Full Text] [Related]
2. Combined medical therapy in the treatment of allergic rhinitis: Systematic review and meta-analyses.
Chitsuthipakorn W; Hoang MP; Kanjanawasee D; Seresirikachorn K; Snidvongs K
Int Forum Allergy Rhinol; 2022 Dec; 12(12):1480-1502. PubMed ID: 35446512
[TBL] [Abstract][Full Text] [Related]
3. Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Khattiyawittayakun L; Snidvongs K
Int Forum Allergy Rhinol; 2018 Oct; 8(10):1083-1092. PubMed ID: 29917324
[TBL] [Abstract][Full Text] [Related]
4. Effects of double-dose intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
Khattiyawittayakun L; Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Snidvongs K
Int Forum Allergy Rhinol; 2019 Jan; 9(1):72-78. PubMed ID: 30179317
[TBL] [Abstract][Full Text] [Related]
5. [Leukotriene receptor antagonist as add-on therapy to intranasal corticosteroids in the treatment of allergic rhinitis: a systematic review].
Feng S; Fan Y; Li L; Chen M; Wang Y; Xu G; Li H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Feb; 29(3):207-11. PubMed ID: 26012288
[TBL] [Abstract][Full Text] [Related]
6. As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis.
Hoang MP; Chitsuthipakorn W; Seresirikachorn K; Snidvongs K
Rhinology; 2022 Aug; 60(4):242-251. PubMed ID: 35379997
[TBL] [Abstract][Full Text] [Related]
7. Effects of decongestant addition to intranasal corticosteroid for chronic rhinitis: a systematic review and meta-analysis.
Khattiyawittayakun L; Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Snidvongs K
Int Forum Allergy Rhinol; 2018 Dec; 8(12):1445-1453. PubMed ID: 30054985
[TBL] [Abstract][Full Text] [Related]
8. Intranasal antihistamine is superior to oral H
Du K; Qing H; Zheng M; Wang X; Zhang L
Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
[TBL] [Abstract][Full Text] [Related]
9. [Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis].
Lu Y; Yin M; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Aug; 49(8):659-67. PubMed ID: 25351124
[TBL] [Abstract][Full Text] [Related]
10. As-needed versus regular intranasal corticosteroid for allergic rhinitis: A systematic review and meta-analysis.
Phinyo P; Wongsa C; Sompornrattanaphan M; Thongngarm T
Asian Pac J Allergy Immunol; 2022 Sep; 40(3):195-204. PubMed ID: 35278059
[TBL] [Abstract][Full Text] [Related]
11. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
Lohia S; Schlosser RJ; Soler ZM
Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
[TBL] [Abstract][Full Text] [Related]
12. Effect of Medical Therapy in Allergic Rhinitis: A Systematic Review and Meta-Analysis.
Zhang K; Li AR; Miglani A; Nguyen SA; Schlosser RJ
Am J Rhinol Allergy; 2022 Mar; 36(2):269-280. PubMed ID: 34546814
[TBL] [Abstract][Full Text] [Related]
13. Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds?
Meltzer EO; Wallace D; Dykewicz M; Shneyer L
J Allergy Clin Immunol Pract; 2016; 4(4):682-688.e6. PubMed ID: 27084419
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Montelukast in Allergic Rhinitis Treatment: A Systematic Review and Meta-Analysis.
Krishnamoorthy M; Mohd Noor N; Mat Lazim N; Abdullah B
Drugs; 2020 Nov; 80(17):1831-1851. PubMed ID: 32915441
[TBL] [Abstract][Full Text] [Related]
15. The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials.
Rodrigo GJ; Yañez A
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):779-86. PubMed ID: 16802764
[TBL] [Abstract][Full Text] [Related]
16. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
17. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis.
Valenzuela CV; Liu JC; Vila PM; Simon L; Doering M; Lieu JEC
Laryngoscope; 2019 Jan; 129(1):6-12. PubMed ID: 30229924
[TBL] [Abstract][Full Text] [Related]
19. Intranasal spray medications for maintenance therapy of allergic rhinitis.
Berger WE; Meltzer EO
Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
[TBL] [Abstract][Full Text] [Related]
20. Cedar and cypress pollinosis and allergic rhinitis: quality of life effects of early intervention with leukotriene receptor antagonists.
Sasaki K; Okamoto Y; Yonekura S; Okawa T; Horiguchi S; Chazono H; Hisamitsu M; Sakurai D; Hanazawa T; Okubo K
Int Arch Allergy Immunol; 2009; 149(4):350-8. PubMed ID: 19295239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
